186 related articles for article (PubMed ID: 20948309)
21. AMP-activated protein kinase suppresses the in vitro and in vivo proliferation of hepatocellular carcinoma.
Cheng J; Huang T; Li Y; Guo Y; Zhu Y; Wang Q; Tan X; Chen W; Zhang Y; Cheng W; Yamamoto T; Jing X; Huang J
PLoS One; 2014; 9(4):e93256. PubMed ID: 24709998
[TBL] [Abstract][Full Text] [Related]
22. A possible role for AMP-activated protein kinase activated by metformin and AICAR in human granulosa cells.
Kai Y; Kawano Y; Yamamoto H; Narahara H
Reprod Biol Endocrinol; 2015 Apr; 13():27. PubMed ID: 25889494
[TBL] [Abstract][Full Text] [Related]
23. 5'-AMP-Activated Protein Kinase Regulates Papillary (TPC-1 and BCPAP) Thyroid Cancer Cell Survival, Migration, Invasion, and Epithelial-to-Mesenchymal Transition.
Cazarin JM; Coelho RG; Hecht F; Andrade BM; Carvalho DP
Thyroid; 2016 Jul; 26(7):933-42. PubMed ID: 27121619
[TBL] [Abstract][Full Text] [Related]
24. AICAR enhances the cytotoxicity of PFKFB3 inhibitor in an AMPK signaling-independent manner in colorectal cancer cells.
Yan S; Yuan D; Li Q; Li S; Zhang F
Med Oncol; 2021 Nov; 39(1):10. PubMed ID: 34761330
[TBL] [Abstract][Full Text] [Related]
25. Activation of the AMP-activated protein kinase reduces inflammatory nociception.
Russe OQ; Möser CV; Kynast KL; King TS; Stephan H; Geisslinger G; Niederberger E
J Pain; 2013 Nov; 14(11):1330-40. PubMed ID: 23916727
[TBL] [Abstract][Full Text] [Related]
26. Cytotoxic effect of 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside (AICAR) on childhood acute lymphoblastic leukemia (ALL) cells: implication for targeted therapy.
Sengupta TK; Leclerc GM; Hsieh-Kinser TT; Leclerc GJ; Singh I; Barredo JC
Mol Cancer; 2007 Jul; 6():46. PubMed ID: 17623090
[TBL] [Abstract][Full Text] [Related]
27. AICAR induces cyclooxygenase-2 expression through AMP-activated protein kinase-transforming growth factor-beta-activated kinase 1-p38 mitogen-activated protein kinase signaling pathway.
Chang MY; Ho FM; Wang JS; Kang HC; Chang Y; Ye ZX; Lin WW
Biochem Pharmacol; 2010 Oct; 80(8):1210-20. PubMed ID: 20615388
[TBL] [Abstract][Full Text] [Related]
28. AICAR and metformin, but not exercise, increase muscle glucose transport through AMPK-, ERK-, and PDK1-dependent activation of atypical PKC.
Sajan MP; Bandyopadhyay G; Miura A; Standaert ML; Nimal S; Longnus SL; Van Obberghen E; Hainault I; Foufelle F; Kahn R; Braun U; Leitges M; Farese RV
Am J Physiol Endocrinol Metab; 2010 Feb; 298(2):E179-92. PubMed ID: 19887597
[TBL] [Abstract][Full Text] [Related]
29. AICAR and compound C negatively modulate HCC-induced primary human hepatic stellate cell activation in vitro.
Böttcher K; Longato L; Marrone G; Mazza G; Ghemtio L; Hall A; Luong TV; Caruso S; Viollet B; Zucman-Rossi J; Pinzani M; Rombouts K
Am J Physiol Gastrointest Liver Physiol; 2021 Apr; 320(4):G543-G556. PubMed ID: 33406006
[TBL] [Abstract][Full Text] [Related]
30. Preclinical evidence of the enhanced effectiveness of combined rapamycin and AICAR in reducing kidney cancer.
Liang S; Medina EA; Li B; Habib SL
Mol Oncol; 2018 Nov; 12(11):1917-1934. PubMed ID: 30107094
[TBL] [Abstract][Full Text] [Related]
31. AMPK and Akt determine apoptotic cell death following perturbations of one-carbon metabolism by regulating ER stress in acute lymphoblastic leukemia.
Kuznetsov JN; Leclerc GJ; Leclerc GM; Barredo JC
Mol Cancer Ther; 2011 Mar; 10(3):437-47. PubMed ID: 21262957
[TBL] [Abstract][Full Text] [Related]
32. Anti-inflammatory activities of fenoterol through β-arrestin-2 and inhibition of AMPK and NF-κB activation in AICAR-induced THP-1 cells.
Wang W; Chen J; Li XG; Xu J
Biomed Pharmacother; 2016 Dec; 84():185-190. PubMed ID: 27657826
[TBL] [Abstract][Full Text] [Related]
33. PARP-1 promotes autophagy via the AMPK/mTOR pathway in CNE-2 human nasopharyngeal carcinoma cells following ionizing radiation, while inhibition of autophagy contributes to the radiation sensitization of CNE-2 cells.
Chen ZT; Zhao W; Qu S; Li L; Lu XD; Su F; Liang ZG; Guo SY; Zhu XD
Mol Med Rep; 2015 Aug; 12(2):1868-76. PubMed ID: 25872765
[TBL] [Abstract][Full Text] [Related]
34. Disruption of AMPKalpha1 signaling prevents AICAR-induced inhibition of AS160/TBC1D4 phosphorylation and glucose uptake in primary rat adipocytes.
Gaidhu MP; Perry RL; Noor F; Ceddia RB
Mol Endocrinol; 2010 Jul; 24(7):1434-40. PubMed ID: 20501641
[TBL] [Abstract][Full Text] [Related]
35. Treatment with AICAR inhibits blastocyst development, trophectoderm differentiation and tight junction formation and function in mice.
Calder MD; Edwards NA; Betts DH; Watson AJ
Mol Hum Reprod; 2017 Nov; 23(11):771-785. PubMed ID: 28962017
[TBL] [Abstract][Full Text] [Related]
36. Overexpression of CYP2E1 induces HepG2 cells death by the AMP kinase activator 5'-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside (AICAR).
Zhuge J
Cell Biol Toxicol; 2009 Jun; 25(3):253-63. PubMed ID: 18473182
[TBL] [Abstract][Full Text] [Related]
37. 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside inhibits cancer cell proliferation in vitro and in vivo via AMP-activated protein kinase.
Rattan R; Giri S; Singh AK; Singh I
J Biol Chem; 2005 Nov; 280(47):39582-93. PubMed ID: 16176927
[TBL] [Abstract][Full Text] [Related]
38. AMP-activated protein kinase inhibits IL-6-stimulated inflammatory response in human liver cells by suppressing phosphorylation of signal transducer and activator of transcription 3 (STAT3).
Nerstedt A; Johansson A; Andersson CX; Cansby E; Smith U; Mahlapuu M
Diabetologia; 2010 Nov; 53(11):2406-16. PubMed ID: 20652679
[TBL] [Abstract][Full Text] [Related]
39. Effects of stimulation of AMP-activated protein kinase on insulin-like growth factor 1- and epidermal growth factor-dependent extracellular signal-regulated kinase pathway.
Kim J; Yoon MY; Choi SL; Kang I; Kim SS; Kim YS; Choi YK; Ha J
J Biol Chem; 2001 Jun; 276(22):19102-10. PubMed ID: 11262401
[TBL] [Abstract][Full Text] [Related]
40. AICAR-induced activation of AMPK negatively regulates myotube hypertrophy through the HSP72-mediated pathway in C2C12 skeletal muscle cells.
Egawa T; Ohno Y; Goto A; Ikuta A; Suzuki M; Ohira T; Yokoyama S; Sugiura T; Ohira Y; Yoshioka T; Goto K
Am J Physiol Endocrinol Metab; 2014 Feb; 306(3):E344-54. PubMed ID: 24347059
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
